Brandi Roberts insider trades

Open-market stock purchases and sales by Brandi Roberts, Chief Financial Officer at Definium Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2011.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
Jun 25, 2026DFTX Definium Therapeutics, IncSold$136K
Jun 22, 2026DFTX Definium Therapeutics, IncBought (not open market)—
Feb 3, 2026DFTX Definium Therapeutics, IncBought (not open market)—

Companies traded

  • DFTX Definium Therapeutics, Inc: 1 sale, last Jun 25, 2026
  • MNMD Mind Medicine (MindMed) Inc: other filings, last Jun 2, 2025
  • LBPH Longboard Pharmaceuticals, Inc: other filings, last Dec 2, 2024
  • TFFP TFF Pharmaceuticals, Inc: 1 buy, last Jul 3, 2024
  • LCTX Lineage Cell Therapeutics, Inc: 1 buy, last Mar 17, 2020
  • BTX Biotime Inc: other filings, last Jun 30, 2019
  • RVA.AX REVA Medical, Inc: 1 buy, last Jun 29, 2018
  • RVA:AX REVA Medical, Inc: other filings, last Sep 18, 2017
  • MSTX Mast Therapeutics, Inc: 2 buys, last Jan 20, 2017
  • ANX Adventrx Pharmaceuticals Inc: other filings, last Jan 2, 2013

Get free alerts when Brandi Roberts files a new trade →